Endocrinology Flashcards
(91 cards)
T1DM risk factors
HLA DR3-DQ2 or HLA DR4-DQ8
Autoimmune diseases
T1DM pathophysiology
Autoantibodies attack Beta cells in the Islets of Langerhans -> Insulin deficiency -> hyperglycaemia
Continuous breakdown of glycogen from liver (gluconeogenesis) -> glycosuria
T1DM diagnosis
Random plasma glucose > 11mmol/L
T1DM management
Education
Insulin
Short-acting insulins and insulin analogues - 4-6 hours
Longer acting insulin - 12-24 hours
T2DM risk factors
Lifestyle factors: obesity, lack of exercise, calorie and alcohol excess
Higher prevalence in asian men
> 40 years old - later onset
Hypertension
T2DM investigation results
Fasting plasma glucose > 7 mmol/L
Random plasma glucose > 11 mmol/L
OGTT after 2 hours > 11 mmol/L
HbA1c > 48 mmol/L
Impaired glucose tolerance investigation results
Fasting plasma glucose > 6 mmol/L
OGTT after 2 hours > 7.8 mmol/L
T2DM lifestyle changes as 1st line management
Dietary advice: high in complex carbs, low in fat
Smoking cessation
Decrease alcohol intake
Encourage exercise
Regular blood glucose and HbA1c monitoring
T2DM pharmacological management
1st: Metformin
[+ SGLT-2 inhibitors if heart failure!]
2nd:
Dual therapy: + SGLT-2 inhibitor, sulphonylurea, pioglitazone, DPP4 inhibitors
3rd:
Triple therapy
4th:
Insulin
Injectables are last line
DKA pathophysiology
Absence of insulin -> uncontrolled catabolism -> unrestrained gluconeogenesis and decreased peripheral glucose uptake -> hyperglycaemia
Hyperglycemia -> osmotic diuresis -> dehydration
Peripheral lipolysis for energy -> increase in circulating free fatty acids -> oxidised to Acetyl CoA -> ketone bodies (acidic) = Acidosis
DKA general management
IV fluids - 0.9% saline
IV insulin
K+ replacement
Hyperosmolar hyperglycaemic state pathophysiology
Low insulin -> increased gluconeogenesis -> hyperglycaemia, but enough insulin to inhibit ketogenesis
Hyperglycemia -> osmotic diuresis -> dehydration
Hyperosmolar hyperglycaemic state investigation results
Random plasma glucose >11mmol/L
Urine dipstick: glucosuria
Plasma osmolality - high
U+E - ↓ total body K+, ↑ serum K+
Hyperosmolar hyperglycaemic state treatment
Replace fluid - 0.9% saline IV
Insulin - At low rate of infusion!
Restore electrolytes - e.g. K+
LMWH
Hyperosmolar hyperglycaemic state manifestations
Extreme diabetes symptoms
Plus:
Confusion and reduced mental state
Lethargy
Severe dehydration
Hyperthyroidism risk factors
Smoking
Stress
HLA-DR3
Other autoimmune diseases: T1DM, Addisons, Vitiligo
Causes of hyperthyroidism
Graves disease - 65-75%, Autoimmune, F>M - 9:1
Toxic multinodular goitre
Toxic adenoma
Metastatic follicular thyroid cancer
Iodine excess (e.g. IV contrast)
Secondary causes - TSH secreting pituitary tumour
Hyperthyroidism pathophysiology
↑T3 increases metabolic rate, cardiac output, bone resorption and activates sympathetic nervous system
Grave’s disease pathophysiology
IgG autoantibodies (anti-TSHR-Ab) bind to TSH receptors to increase T4/T3 production
They also react with orbital autoantigens
Hyperthyroidism presentation
Hot + sweaty
Diarrhoea
Hyperphagia
Weight loss
Palpitations
Tremor
Irritability
Anxiety/restlessness
Oligomenorrhoea
Goitre
Grave’s disease: eye symptoms + other
Thyroid eye disease (25-50%)
Eyelid retraction
Periorbital swelling
Proptosis/Exophthalmos
Pretibial myxoedema
Thyroid acropachy
Hyperthyroidism TFTs + antibodies + other investigations
TFTs - ↑T4/T3, Primary: ↓TSH, Secondary: ↑TSH
Thyroid autoantibodies (anti-TSHR)
US + CT Head
Hyperthyroidism management
Drug management
Beta-blockers - Rapid symptom relief
1st line Carbimazole - Blocks synthesis of T4
2nd line Propylthiouracil - Prevents T4->T3 conversion
Radioiodine
Thyroidectomy
Most common cause of hypothyroidism worldwide
Iodine deficiency